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Poloxamer 407 gela b s t r a c t
In order to avoid the risks of sideeffects of epidural local anesthetics and opioids, the use of nonsteroidal
anti-inflammatory drugs (NSAIDs) epidurally would be an interesting option of analgesic therapy. The
fairly short duration of action of spinally administered NSAIDs, e.g., ibuprofen, may be prolonged by using
controlled release poloxamer gel formulation. Using a microdialysis technique we studied the epidural
and intrathecal pharmacokinetics of ibuprofen after its epidural administration as a poloxamer 407 for-
mulation or a solution formulation. In addition, plasma ibuprofen concentrations were analyzed from
central venous blood samples. Ibuprofen concentrations in the epidural space were significantly higher
and longer lasting after the epidural gel injection compared with the epidural solution injection. The
epidural AUC of ibuprofen was over threefold greater after epidural ibuprofen gel injection compared
with the ibuprofen solution injection (p < 0.001). The systemic absorption of ibuprofen from 25% polox-
amer 407 gel was very low. The in situ forming poloxamer gel acted as a reservoir allowing targeted
ibuprofen release at the epidural injection site and restricted ibuprofen molecules to a smaller spinal
area. Ibuprofen diffusion from the epidural space to the intrathecal space was steady and prolonged.
These results demonstrate that the use of epidurally injectable poloxamer gel can increase and prolong
ibuprofen delivery from epidural space to the CSF enhancing thus ibuprofen entry into the central neu-
roaxis for spinal analgesia. Further toxicological and dose-finding studies are justified.
 2016 Elsevier B.V. All rights reserved.1. Introduction
Different systems to control epidural drug release have been
studied during the last years, including the use of lipid solutions
[1], cyclodextrin [2], liposomes [3], microparticles [4,5] and emul-
sified solutions [6]. The results have been to some extent conflict-
ing [7], and only bupivacaine liposomes have been studied
epidurally in humans [8,9]. So far, to our knowledge, for general
clinical epidural use there is only one slow-release liposome pro-
duct of morphine available on market (DepoDur) [10]. One bupi-
vacaine liposome formulation is on market for regional pain
treatment (Exparel), but it is not indicated for epidural or
intrathecal use [11].
Intravenously administered non-steroidal anti-inflammatory
drugs (NSAIDs) can penetrate into the CSF [12,13] and some have
been administered intrathecally in pain patients [14]. The possibil-ity of using indomethacine instead of corticosteroids epidurally has
been explored in patients with postlaminectomy syndrome [15].
The spinal analgesic and anti-inflammatory effects of nonsteroidal
anti-inflammatory drugs (NSAIDs) seem to be related to their abil-
ity to inhibit cyclo-oxygenase enzyme and the synthesis of prosta-
glandins [16,17], thus blocking the excessive sensitivity to pain
induced by the activation of the spinal glutamate and substance
P receptors [18,19]. Since NSAIDs act through an enzymatic system
instead of receptors the risks of spinal opioids, such as tolerance,
respiratory depression, urinary problems, motor blockade and
dependence [20] are unlikely to develop in epidural use of NSAIDs.
Ibuprofen is known as a potent oral NSAID, but has been found to
be able to act also on the spinal cord reducing pain even more effi-
ciently after intrathecal administration than after systemic admin-
istration [18]. Ibuprofen can produce significant analgesia after
epidural administration [21], but the biological half-life of ibupro-
fen is fairly short (t1/2 2 h).
In epidural analgesia and anesthesia it would be important that
the application of drug molecules is localized near the epidural
injection site and spot-targeted drug delivery through the spinal
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Poloxamer is a biocompatible polymer widely used for medical
and pharmaceutical purposes. Different poloxamer grades have
been under study for ocular, nasal, topical, rectal, vaginal and uter-
ine use, and are also used in oral preparations. Because of polox-
amer’s low toxicity and weak immunogenic properties it has been
considered suitable also for parenteral drug delivery [22–26]. The
reverse phase thermal gelation of the 25% (w/w) poloxamer gel
makes it an easily injectable liquidwhen cold (5–10 C) and it forms
a highly viscous gel in situ at a physiological body temperature.
We have previously shown controlled release of ibuprofen
through porcine dura mater in vitro from an ibuprofen-
poloxamer 407 gel [27]. In vivo lumbar epidural injection of
ibuprofen containing poloxamer 407 gel to pigs resulted in analge-
sia to pinching and reduced systemic absorption of ibuprofen [28].
Epidurally administered ibuprofen does not cause motor blockade
[19,28], and in this respect ibuprofen can also be regarded as a
promising drug for post-operative spinal pain treatment.
The fate of epidurally administered ibuprofen is not clear, and
details of the spinal area kinetics after controlled release epidural
poloxamer gel injection are needed. Our hypothesis is that ibupro-
fen concentration at the epidural injection site can probably be
maintained by poloxamer gel and ibuprofen could be ‘‘transferred”
into intrathecal space in adequate amounts and for a prolonged
length of time to produce analgesia at the spinal cord level. The
knowledge of ibuprofen epidural pharmacokinetics would be crit-
ical for optimizing ibuprofen spinal dose.
The present in vivo study in pigs was designed to characterize
and compare the distribution of ibuprofen in the spinal area after
an epidural bolus injection of ibuprofen in poloxamer gel or in sal-
ine. Ibuprofen concentrations in epidural and intrathecal space as
well as in plasma were investigated using microdialysis techniques
which allowed continuous sampling from the spinal spaces.
2. Materials and methods
2.1. Drug formulation
The poloxamer gel was prepared as previously using the cold
preparation technique [29]. An appropriate amount (25% w/w) of
poloxamer 407 ((HO(C2H4O)101(C3H6O)56(C2H4O)101H, i.e., poly-
oxyethylene - polyoxypropylene block co-polymer) (Lutrol F-127,
BASF, USA) was added into a cold solution (5 ± 1 C) while main-
taining constant agitation with a magnetic stirrer. The gel was
stored at 4 C until a clear solution was formed. IbuprofenNa
(C13H17NaO2, i.e., sodium 2-[4-(2-methylpropyl) phenyl] propi-
onate) (Knoll Pharm., United Kingdom) (2% corresponding to 1.6%
ibuprofen) was added in the gel and the pH was adjusted carefully
to 7.4 with HCl solution. The pH was measured with a pH meter
(Mettler, Halstend, UK) while the gel was in the liquid state at
4 C. IbuprofenNa-solution (2%) was used as the control
formulation.
The viscosity measurement was a quality control method to
assess the behavior of the gel at body temperature. The apparent
viscosity value of the 2% ibuprofenNa containing 25% poloxamer
gel was after 10 min rotation at 37 C 67.1 ± 1.8 Pas (Brookfield
digital rheometer DV-III, spindle RV7, Brookfield RVT laboratories,
Stoughton, USA). The temperature of the gel samples was adjusted
to 37 C using a thermostated water jacket.
2.2. Microdialysis experiment
2.2.1. Animals
The animal study was approved by the University of
Washington’s Institutional Animal Care and Use Committee(Seattle, Washington). The guidelines of American Association for
Laboratory Animal Care (NIH Publications) for the use of experi-
mental animals were followed throughout the experiments. The
animals used were healthy farm-raced pigs (n = 12) weighing
11–14 kg. Before the experiment the animals were on ad libitum
diet and they were housed in a 12 h light-dark cycled rooms. The
animals were euthanized after the experiment.
The animals were randomly divided into two main study
groups: ibuprofen solution (n = 6) and ibuprofen poloxamer gel
(n = 6) groups. The animals were anesthetized by mask inhalation
with halothane (1–2%) and nitrous oxide (70%) in oxygen. The
muscle functions were controlled by an intramuscular succinyl-
choline injection (100 mg). The orotracheal tube was placed and
anesthesia was maintained with isoflurane (1–2%) in balance oxy-
gen. Animals were mechanically ventilated to maintain end-tidal
CO2 between 36 and 40 mmHg. A Datex (Helsinki, Finland) model
F-W8-28-01 airway gas analyzer was used to measure end-tidal
CO2 and isoflurane concentrations. The body temperature of the
anesthetized animal was maintained at 37–38 C by a heat-lamp
controlled by a rectal thermometer system. The right femoral
artery of the animal was cannulated for blood sampling. Blood
pressure and heart rate were measured by pressure transducer.
The transducers used were Hospira Transpac IV Monitoring Kit
(Hospira Inc., Lake Forest, Il, USA). Saline solution infusion was
given as a maintenance fluid through the cannulated right femoral
vein and was administered at the rate of 4 ml/kg/h using volume
controlled pump (Abbot/Shaw Lifecare Pump Model 4, Abbot
Laboratories, Alameda, CA, USA).
2.2.2. Implantation of microdialysis probes and drug administration
The microdialysis technique used was a slightly modified
version of the method previously used in this laboratory for local
anesthetic analysis [30,31]. Using microsurgical technique, the
vertebral laminas were exposed posteriorly between T11 and
L5. The epidural probe was inserted through the ligamentum
flavum between L1 and L2 and was directed cephalad in the
posterior epidural space. The intrathecal probe was directed
caudal in the subarachnoid space. The probes were secured to
be in place by cyanoacrylate glue. The microdialysis probes were
made from cellulose dialysis fibers (Spectrum Medical Industries,
Inc., Houston, Texas) with a 215 lm inside diameter, a 235 lm
outside diameter, and a molecular weight cutoff of 6000 Daltons.
The probes were perfused with bicarbonate buffered mock
cerebral spinal fluid (NaCl 140 mEq, NaHCO3 25 mEq, KCl
2.9 mEq, MgCl2 0.4 mEq, urea 3.5 mEq, glucose 4.0 mEq, CaCl2
2.0 mEq; pH = 7.38–7.42; 292–298 mOsm) through which 5%
CO2/ 95% air gas was bubbled. The microdialysis probes were
connected to the cellulose tubing and syringe pump. The syringe
pump (Harvard Apparatus Inc., model 22, Holliston, MA) was
used to pump mock CSF through the dialysis probes at the rate
of 10 ll/min.
The 2% ibuprofenNa containing poloxamer gel or 2%
ibuprofenNa solution was administered as a single dose epidural
injection into the 5th lumbar interspace through a single G20
epidural catheter (B Braun Medical, Bethlehem, PA) connected to
a syringe pump (Harvard apparatus, USA) using a speed of
2 ml/min. The formulations were injected cold (4–8 C) when the
gel was in the liquid state.
At the end of the experiments Richardson’s blue was injected
into the epidural space via the epidural catheter. The spinal cord
and epidural catheter were removed. The intrathecal catheter
was removed and the spinal cord was longitudinally sectioned to
ascertain that the spinal membranes had remained intact,
excluding the catheter insertion holes, and the tissue samples were
examined under a dissecting microscope.
Table 1
Epidural pharmacokinetic parameters after epidural injection of 40 mg dose of
ibuprofen poloxamer gel (n = 6) or ibuprofen solution (n = 6). Means ± SEM are
presented.
Parameter Gel Solution
AUC0-1 (lg/mlmin1) 12572 ± 7860⁄⁄⁄ 3588 ± 711
AUC0-t (lg/mlmin1) 9832 ± 5612⁄⁄ 3530 ± 707
Cmax (lg/ml)a 614 ± 271⁄⁄ 1189 ± 286
tmax (min)a 34.1 ± 18.5⁄⁄ 5.1 ± 0.1
MRT (min) 209 ± 43⁄⁄⁄ 38.2 ± 7.4
t½ (min) 132 ± 78⁄⁄⁄ 31.2 ± 6.1
Significant difference *p < 0.05, **p < 0.01, ***p < 0.001 compared with epidural
solution.
a The Cmax and tmax are apparent values.
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2.3.1. Epidural and intrathecal ibuprofen concentration assay
Dialysis samples from epidural and intrathecal spaces were col-
lected at 0, 5, 10, 15, 20, 25, 30, 40, 50, 60 min and then every
20 min until 240 min after the ibuprofen gel or ibuprofen solution
injection. The samples were stored at 20 C until analysis.
Ibuprofen concentrations of the epidural and intrathecal
dialysate and plasma samples were determined by HPLC at a
wavelength of 222 nm using a modified version of a method
described by Minkler and Hoppel [32]. A supelcosil LC-18DB
column (Supelco, 5 lm, 125 Å, 1.6  1500 mm) (Waters Ltd.,
USA-Milford) was used at ambient temperature. The isocratic
mobile phase was acetonitrile: deionized water (40:60 v/v), and
the pH was adjusted to 6.2 with phosphoric acid. The flow rate
was 2 ml/min. The accuracy and reproducibility of the method
were assessed according to recommendations [33]. The coefficient
of variation of intra-assay variability was 3% or less. The detection
limit was 0.05 lg/ml.
2.3.2. Plasma ibuprofen concentration assay
Blood samples were collected into EDTA tubes from the cannu-
lated right brachial vein 0, 5, 10, 20, 30, 60, 90, 120, 150, 180 and
240 min after the injection. Plasma was separated by centrifuga-
tion at 3000 rpm for 10 min and stored in plastic tubes at 20 C
until analysis.
Ibuprofen plasma concentrations were determined using high
performance liquid chromatography (HPLC) at a wavelength of
222 nm using a slightly modified version of a method described
by Averginos and Hutt [34]. A reversed-phase C18 column (lBonda-
pak 10 lm, 125 Å, 3.9  300 mm) (Waters Ltd., USA-Milford) com-
bined with a guard column (lBondapak) was used at ambient
temperature. The isocratic mobile phase was acetonitrile: 0.1 M
sodium acetate (35:65 v/v), and the pH was adjusted to 6.2 with
glacial acetic acid. The flow rate was 2 ml/min. The accuracy of
the method was tested according to recommendations [33]. The
reproducibility of the method was investigated by the repeated
analysis (n = 6) of plasma samples spiked with ibuprofen at con-
centrations of 0.1 and 20 lg/ml. The coefficient of variation of
intra-assay variability was 2% or less. The detection limit was
0.05 lg/ml.
2.3.3. Pharmacokinetic parameters and statistics
The pharmacokinetic parameters assessed from the epidural
and intrathecal microdialysis samples and the plasma samples
were the maximum epidural dialysate, intrathecal dialysate and
plasma concentration (Cmax), as well as the time of peak epidural
dialysate, intrathecal dialysate and plasma concentration (tmax),
the area under the concentration-time curve from time zero to
infinity (AUC0-1), the area under the concentration-time curveFig. 1. Mean epidural dialysis concentrations of ibuprofen in pigs after epidural
injection of 40 mg ibuprofen in poloxamer gel or solution. Means ± SEM are
presented. Symbols: j gel (n = 6), h solution (n = 6).from time zero to the last measured point (AUC0-t), the apparent
elimination half-life (t½), and the mean residence time (MRT).
The analyses were performed with PK Solution 2.0 software (Sum-
mit Research Services, Montrose, Colorado, USA). The measured
Cmax and tmax values were used as such. The AUC and MRT values
were calculated according to the trapezoidal method without log-
arithmic transformation.
The results are expressed as means ± SEM. Statistical analysis
was performed. Intergroup comparisons for all data were per-
formed using analysis of variance (ANOVA). tmax values have been
analyzed by Mann-Whitney U test. For all analyses, differences
were considered statistically significant at a value of p < 0.05.3. Results
3.1. Epidural space pharmacokinetics
The ibuprofen concentrations after the poloxamer gel injection
were much lower but lasted much longer as compared with the
solution injection (Fig. 1). The epidural AUC values were signifi-
cantly higher after epidural gel injection of ibuprofen compared
with the corresponding solution injection (Table 1). The maximum
epidural concentration of ibuprofen (1189 lg/ml) was reached
5 min after the epidural injection of ibuprofen solution, while the
Cmax (614 lg/ml) after the gel injection was reached in 34 min.
The MRT and t½ values were significantly (p < 0.001) longer after
the gel injection than after the solution injection.3.2. Intrathecal space pharmacokinetics
The difference in the intrathecal concentrations of ibuprofen
after the epidural gel injection compared with epidural solutionFig. 2. Mean intrathecal dialysis concentrations of ibuprofen in pigs after epidural
injection of 40 mg ibuprofen in poloxamer gel or solution. Means ± SEM are
presented. Symbols: j gel (n = 6), h solution (n = 6).
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cal Cmax (45 lg/ml) was reached in 55 min while after solution
injection Cmax (238 lg/ml) occurred after 11 min (Table 2). The
MRT of ibuprofen increased significantly (p < 0.001) after epidural
injection of the gel (131 min) as compared with the solution
(43 min). The elimination t½ time for ibuprofen was also signifi-
cantly (p < 0.001) longer after the gel injection compared with
the solution.3.3. Systemic absorption
The epidural injection of ibuprofen gel prolonged the absorp-
tion of ibuprofen into blood compared with the epidural solution
injection of ibuprofen (Fig. 3). The maximum plasma ibuprofen
concentration (Cmax 2.3 lg/ml) after the epidural gel injection
was reached at about 1 h, while after solution injection Cmax
(9.8 lg/ml) was reached already 35 min earlier (Table 3). The
MRT and t½ values were significantly larger after the gel injection
compared with the solution. Furthermore, the AUC values were
significantly smaller (p < 0.001) after epidural gel injectionTable 2
Intrathecal pharmacokinetic parameters after epidural injection of 40 mg dose of
ibuprofen poloxamer gel (n = 6) or ibuprofen solution (n = 6). Means ± SEM are
presented.
Parameter Gel Solution
AUC0-1 (lg/mlmin1) 3850 ± 2766⁄⁄⁄ 647 ± 514
AUC0-t (lg/mlmin1) 3516 ± 2644⁄⁄⁄ 645 ± 512
Cmax (lg/ml)a 45.9 ± 17.7⁄⁄ 238 ± 208
tmax (min)a 55.0 ± 5⁄⁄ 11.1 ± 5.8
MRT (min) 131 ± 33⁄⁄⁄ 43.8 ± 24.7
t½ (min) 86.8 ± 51⁄⁄ 31.1 ± 7.4
Significant difference *p < 0.05, **p < 0.01, ***p < 0.001 compared with epidural
solution.
a The Cmax and tmax are apparent values.
Fig. 3. Mean plasma concentrations of ibuprofen in pigs after epidural injection of
40 mg ibuprofen in poloxamer gel or solution. Means ± SEM are presented.
Symbols: j gel (n = 6), h solution (n = 6).
Table 3
Plasma pharmacokinetic parameters after epidural injection of 40 mg dose of
ibuprofen poloxamer gel (n = 6) or ibuprofen solution (n = 6). Means ± SEM are
presented.
Parameter Gel Solution
AUC0-1 (lg/mlmin1) 622 ± 426⁄⁄⁄ 1121 ± 382
AUC0-t (lg/mlmin1) 604 ± 284⁄⁄ 942 ± 368
Cmax (lg/ml)a 2.34 ± 1.15⁄⁄ 9.8 ± 2.3
tmax (min)a 58.2 ± 14.7⁄⁄ 24.2 ± 4.8
MRT (min) 45.9 ± 10.4⁄⁄⁄ 31.0 ± 31
t½ (min) 23.0 ± 9.1⁄⁄⁄ 19.1 ± 34.9
Significant difference *p < 0.05, **p < 0.01, ***p < 0.001 compared with epidural
solution.
a The Cmax and tmax are apparent values.(604 lg/mlmin1) compared with the epidural solution injection
(942 lg/mlmin1).4. Discussion
4.1. Epidural and intrathecal concentrations
An important finding was that the intrathecal AUC of ibuprofen
was significantly larger after epidural poloxamer gel injection com-
pared with the epidural solution injection (Tables 1 and 2). The
ibuprofen concentrations in the epidural and intrathecal spaces
remained at a steady-state level in the poloxamer gel group for a
long time (Figs. 1 and 2). The cold 25% poloxamer gel injected into
the epidural space rapidly forms a soft but compact 2–3 cm wide
structure of poloxamer gel at and around the epidural injection site
[28]. Ibuprofen is an amphiphilic molecule containing both hydro-
philic and hydrophobic regions [35,36], and it forms micelles in
solutions [37]. The micelle forming capacity of ibuprofen in solu-
tions probably decreases the surface tension at the dural mem-
brane interface thus speeding up ibuprofen molecule diffusion.
Interestingly the epidural Cmax of ibuprofen after ibuprofen solu-
tion administration was lower than expected based on the dose
administered. Due to ibuprofen’s lipophilic nature, part of the dose
may have rapidly distributed into epidural tissues, and into epidu-
ral fat in particular. The lipophilicity of the epidurally administered
drug may have a significant impact on the spinal kinetics through
uptake in epidural tissues, in particular epidural fat [38]. The more
lipophilic the local anesthetics the more drug has been shown to be
absorbed in epidural fat [39–41]. Theoretical lipophilicity of
ibuprofen (logP 4.0) is near to that of the commonly used epidural
anesthetic bupivacaine (logP 3.4) and analgesic sufentanil (logP
3.5). The pKa of ibuprofen is low, i.e., 3.5 [42], which suggests
strong ionization at physiological pH. Therefore, ibuprofen in the
epidural space fairly poorly penetrates membranes, unlike more
lipophilic drugs, e.g. local anesthetics and morphine [38]. On the
other hand, because of a carboxyl group in the molecular structure,
ibuprofen is able to form hydrogen bonds with various epidural tis-
sue structural components, which also can lead to a reduced
amount of ibuprofen in the epidural space. The epidural AUC of
ibuprofen was, however, over threefold larger after epidural
ibuprofen gel injection compared with the ibuprofen solution
injection (p < 0.001) suggesting that the bioavailability of ibupro-
fen in the CSF was improved by 25% poloxamer gel.
Based on the rate parameter results (MRT, tmax and Cmax) of
epidural and intrathecal samples ibuprofen diffused steadily from
the gel in the epidural space through the spinal membranes into
the intrathecal space and CSF. It remains to be shownwhether such
intrathecal concentrations are able to relieve pain associated with
e.g. surgery. In the rat paw formalin test Malmberg and Yaksh [43]
found that a spinal analgesic effect could be achieved with about
only a one hundredth part of an effective systemic dose of variety
of analgesics, including ibuprofen.4.2. Systemic absorption after epidural injection
Rapid systemic absorption or extensive spread in the CSF of
drug molecules after epidural administration, is the most common
reason of unwanted adverse-effects of epidurally used drugs. The
physicochemical properties of diffusing molecules are important
in determining the permeation of molecules through spinal
meninges and subsequent distribution into blood, CSF and spinal
tissues [41]. As seen in the present study, injection of ibuprofen
solution resulted in initially very high epidural and intrathecal
concentrations (Figs. 1 and 2). This was followed by a relatively
rapid concentration decline, and a concomitant rise in ibuprofen
Fig. 4. Schematic cross-sectional illustration of the spinal canal inside the vertebral
canal of the spine. 1. Ligamentum flavum, 2. Epidural space, 3. Dura mater with
attached arachnoid mater, 4. Intrathecal space, i.e., subarachnoid space with
cerebrospinal fluid (CSF), 5. The spinal cord and CSF.
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the systemic absorption of ibuprofen. Although plasma levels of
ibuprofen after epidural gel administration were very low, and
clearly lower than that (7 lg/ml) was found to reduce pain in
man [44], constant systemic absorption into blood circulation from
spinal area was observed for 3–4 h. The vascular network in the
epidural space and of the meninges are potential sites for any drug
to be cleared into the systemic circulation before they reach the
spinal cord [45].
4.3. Poloxamer gel effects on epidural ibuprofen kinetics
Drug movement through the spinal meninges is diffusion, and
in in vitro studies evidence of active transport or facilitated diffu-
sion of drug molecules has not been seen [46]. After injection of
the ibuprofen solution, fast diffusion through the epidural mem-
brane seems to correlate with fast redistribution into the plasma
and decreased efficacy at the spinal site. Based on the present
study, it can be concluded, that poloxamer gel can improve utiliza-
tion and therapeutic index of epidurally administered ibuprofen.
The gel can permit more accurate targeting of drug molecules to
the specific spinal cord segments responsible for pain because it
prevents wide spread of drug molecules within the epidural space,
which occurs with injected solutions. The amount of ibuprofen
entering the intrathecal space was sixfold higher after ibuprofen
gel compared with solution injection (Tables 1 and 2), and the
escape from epidural space to plasma was significantly reduced
(Table 3). This is in line with and complements our previous
in vitro dura mater permeability findings in which ibuprofen per-
meability through porcine dura mater membrane after solution
injection was fivefold higher compared to that after poloxamer
gel; apparent permeability coefficients being 35.5  106 cm/s
and 7.3  106 cm/s, respectively [27]. In vitro permeability of
ibuprofen through dura mater in case of solution was in the begin-
ning linear as a function of time and continued to be linear as a
function of square root of time from 60 min forward. In contrast,
the cumulative amount of ibuprofen permeated in vitro through
dura matermembrane from the gel as a function of time was linear
[27]. However, in vivo the tight junctions of arachnoid mater seem
to form a strong functional barrier to diffusion in the meninges
which thus can decrease the in vitro observed permeation [46,47].
The innermost structure of poloxamer gel is composed of cubi-
cally orientated micellar subunits where the inner part is
hydrophobic polypropylene oxide and outer polyethylene oxide
part hydrophilic [29,48]. Polyethylene oxide-polypropylene oxide
polymers have been found to increase drug concentration levels
in brain tissues by producing drug accumulation in selected organs
and even overcome blood-brain-barriers intrinsic drug resistance
[49,50]. The intrathecal dialysis concentrations show that 25%
poloxamer gel, in addition to being a diffusion targeting mechani-
cal gel matrix, could act as an ibuprofen absorption increasing sys-
tem on the epidural membrane interface.
Although the fate of drugs given epidurally is complicated, the
amount of drug transferred through the dural membrane from
the epidural space and entering the intrathecal space determines
the anesthetic effect [45,51]. Epidural and intrathecal elimination
of ibuprofen after epidural gel administration (Figs. 1 and 2) was
linear as a function of time, while the elimination after the solution
was more of first order. The poloxamer gel was able to reduce peak
concentrations of ibuprofen and increase its total exposure over
time. Based on our results 25% poloxamer gel could ensure a con-
stant ibuprofen concentration in the spinal nervous tissue and a
prolonged duration of analgesic action, i.e. pain-suppressing activ-
ity. While the redistribution of ibuprofen from epidural space to
blood circulation is minimized by the gel, ibuprofen entry into
the central neuroaxis will be enhanced.4.4. Safety of poloxamer
Poloxamer is compatible with many drugs and forms in situ a
controlled release system increasing residence time of the drug
at the injection site. Many gels have limitations in terms of
strength, e.g. pore size of collagen gels is often too large to control
diffusion [52,53]. The properties of poloxamer gel still seem very
promising for injectable controlled release use, and therefore
meaningful to be studied further. The aqueous systems of polox-
amers 407 are smart, temperature stimuli-responsive chemically
and physically reducible and stable systems [26,54,55]. Poloxamer
407 is generally classified as an inactive molecule and based on the
available data it can be considered as non-toxic and biocompatible
[56]. In rabbits, only very high intraperitoneal doses (140 mg/kg) of
some poloxamer types have resulted in lipid metabolism alter-
ations [57].4.5. Microdialysis and epidural space kinetics
Epidural and intrathecal pharmacokinetics of drugs is a com-
plex area of kinetics. Microdialysis techniques are sensitive meth-
ods with which also distribution of drugs in the spinal area can be
studied [30,58–61]. Structurally the epidural space is the outer-
most part of the spinal canal, which is formed by the surrounding
vertebrae outside the dura mater of the spinal meninges. Dura
mater and arachnoid mater are attached to each other and enclose
the subarachnoid space, i.e., the intrathecal space, the cerebrospinal
fluid, and the spinal cord (Fig. 4). The drug molecules penetrate the
dural and arachnoid membranes, in order to get access to the nerve
roots and the spinal cord in the subarachnoid space. Four main
mechanisms in drug delivery from epidural space are competing,
i.e., diffusion through the spinal meanings, systemic absorption,
distribution into the epidural fat and diffusion through dural nerve
root cuffs [47,62,63]. Of these the amount of drugs diffusing across
the spinal meninges is the most important factor affecting drug
delivery into the spinal cord nerve tissue and thus determining
the analgesic effect after epidural administration. Microdialysis
makes it possible to measure ibuprofen concentrations in the
fluid-free epidural space and the intrathecal space without altering
the dynamics of CSF.4.6. The limitations of describing epidural drug behavior and spinal
drug delivery with microdialysis
It is not ethical or possible to study spinal distribution of drugs
in vivo in humans during formulation development. Microdialysis
allows continuous sampling of spinal region after epidural ibupro-
fen administration and the true pharmacokinetics of the epidural
space can be evaluated. There are some minor differences in spinal
A. Paavola et al. / European Journal of Pharmaceutics and Biopharmaceutics 108 (2016) 180–186 185anatomy between pigs and humans, e.g., in caudal extension of the
spinal cord. However, the background literature data of pigs and
their use in central nervous system studies indicate that regarding
anatomy, physiology and pharmacology pigs very closely resemble
those of humans [64,65]. The possible ibuprofen absorption in the
epidural fat remained as an uncontrollable variable in this study
design, but because of minuscule epidural fat amount in the young
animals ibuprofen absorption into plasma could be considered as
the most prominent epidural bioavailability reducing factor. The
microdialysis method has been used successfully previously for
other commonly epidurally used drugs such as bupivacaine and
opioids [30,31]. It is a reproducible and applicable method.
5. Conclusions
The present microdialysis study indicated that the relative
bioavailability of ibuprofen in the CSF was increased after epidural
injection of the 25% poloxamer 407 gel. The poloxamer gel permit-
ted accurate and effective targeting of ibuprofen to specific spinal
cord segments. It prevented a wide spread of the drug within the
epidural space and allowed controlled drug delivery from the
epidural space into the intrathecal space. It also seemed to dimin-
ish the redistribution of ibuprofen to extraspinal sites, including
plasma. In addition to being a diffusion targeting mechanical gel
matrix, poloxamer gel seemed act as an ibuprofen epidural perme-
ation enhancing system.
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